Advertisement
Australia markets close in 2 hours 6 minutes
  • ALL ORDS

    8,557.70
    -66.40 (-0.77%)
     
  • ASX 200

    8,287.70
    -68.20 (-0.82%)
     
  • AUD/USD

    0.6711
    +0.0012 (+0.18%)
     
  • OIL

    71.01
    +0.34 (+0.48%)
     
  • GOLD

    2,723.00
    +15.50 (+0.57%)
     
  • Bitcoin AUD

    101,432.48
    +837.09 (+0.83%)
     
  • XRP AUD

    0.81
    -0.00 (-0.24%)
     
  • AUD/EUR

    0.6188
    +0.0009 (+0.15%)
     
  • AUD/NZD

    1.1063
    +0.0013 (+0.12%)
     
  • NZX 50

    12,801.08
    +32.54 (+0.25%)
     
  • NASDAQ

    20,190.42
    +16.38 (+0.08%)
     
  • FTSE

    8,385.13
    +56.06 (+0.67%)
     
  • Dow Jones

    43,239.05
    +161.35 (+0.37%)
     
  • DAX

    19,583.39
    +150.58 (+0.77%)
     
  • Hang Seng

    20,341.09
    +261.99 (+1.30%)
     
  • NIKKEI 225

    39,058.32
    +147.13 (+0.38%)
     

Here's Why Henry Schein (HSIC) is a Strong Value Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.

Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.

Why Investors Should Pay Attention to This Value Stock

Value investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, the Value Style Score identifies the most attractive and most discounted stocks.

Henry Schein (HSIC)

Melville, NY-headquartered Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Presently, Henry Schein operates in 33 countries.

HSIC sits at a Zacks Rank #3 (Hold), holds a Value Style Score of A, and has a VGM Score of B. Compared to the Medical - Dental Supplies industry's P/E of 18X, shares of Henry Schein are trading at a forward P/E of 13.6X. HSIC also has a PEG Ratio of 1.7, a Price/Cash Flow ratio of 10.5X, and a Price/Sales ratio of 0.7X.

Many value investors pay close attention to a company's earnings as well. For HSIC, two analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.08 to $5.16 per share for 2024. Per share HSIC boasts an average earnings surprise of 2.6%.

Investors should take the time to consider HSIC for their portfolios due to its solid Zacks Ranks, notable earnings and valuation metrics, and impressive Value and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Henry Schein, Inc. (HSIC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research